Detalles de la búsqueda
1.
A 52-week efficacy and safety study of enavogliflozin versus dapagliflozin as an add-on to metformin in patients with type 2 diabetes mellitus: ENHANCE-M extension study.
Diabetes Obes Metab
; 26(6): 2248-2256, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38456558
2.
Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record-Integrated Mobile App in Patients With Type 2 Diabetes: 6-Month Randomized Controlled Trial.
J Med Internet Res
; 24(7): e37430, 2022 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35900817
3.
Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations.
Diabetes Obes Metab
; 23(2): 299-317, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33155749
4.
Low-density lipoprotein cholesterol reduction and target achievement after switching from statin monotherapy to statin/ezetimibe combination therapy: Real-world evidence.
J Clin Pharm Ther
; 46(1): 134-142, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33026659
5.
Exposure-weighted scoring for metabolic syndrome and the risk of myocardial infarction and stroke: a nationwide population-based study.
Cardiovasc Diabetol
; 19(1): 153, 2020 09 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32993664
6.
Optimal fasting plasma glucose and haemoglobin A1c levels for screening of prediabetes and diabetes according to 2-hour plasma glucose in a high-risk population: The Korean Diabetes Prevention Study.
Diabetes Metab Res Rev
; 36(7): e3324, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32293089
7.
Efficacy and safety of once-monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo-controlled, 16-week randomized dose-finding study.
Diabetes Obes Metab
; 22(7): 1176-1186, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32128957
8.
Pharmacokinetic and dose-finding studies on efpeglenatide in patients with type 2 diabetes.
Diabetes Obes Metab
; 22(8): 1292-1301, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32175655
9.
Real-world data reveal unmet clinical needs in insulin treatment in Asian people with type 2 diabetes: the Joint Asia Diabetes Evaluation (JADE) Register.
Diabetes Obes Metab
; 22(4): 669-679, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31903728
10.
Discontinuation rate and reason for discontinuation after sodium-glucose cotransporter 2 inhibitor prescription in real clinical practice.
J Clin Pharm Ther
; 45(6): 1271-1277, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32533743
11.
Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population.
Circulation
; 138(23): 2627-2637, 2018 12 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30571256
12.
Effect of sodium-glucose cotransporter 2 inhibitor, empagliflozin, and α-glucosidase inhibitor, voglibose, on hepatic steatosis in an animal model of type 2 diabetes.
J Cell Biochem
; 120(5): 8534-8546, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30474134
13.
Long-term insulin treatment leads to a change in myosin heavy chain fiber distribution in OLETF rat skeletal muscle.
J Cell Biochem
; 120(2): 2404-2412, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30230025
14.
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study.
Diabetes Obes Metab
; 21(11): 2429-2439, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31264757
15.
Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations.
Diabetes Obes Metab
; 21(11): 2354-2367, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31264765
16.
Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial.
Diabetes Obes Metab
; 20(10): 2408-2415, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29862619
17.
Variability in Total Cholesterol Is Associated With the Risk of End-Stage Renal Disease: A Nationwide Population-Based Study.
Arterioscler Thromb Vasc Biol
; 37(10): 1963-1970, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28860222
18.
Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.
Eur Heart J
; 38(48): 3560-3566, 2017 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29069458
19.
Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extension.
Diabetes Obes Metab
; 19(5): 654-663, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28058750
20.
Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study).
Diabetes Obes Metab
; 19(1): 87-97, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27619558